Tru Independence Asset Management 2, LLC Johnson & Johnson Transaction History

Tru Independence Asset Management 2, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$151.05 - $180.26 $80,509 - $96,078	-533 Reduced 27.7%	1,391 $215,000
Q3 2022 Oct 31, 2022	BUY	$161.33 - $179.52 $36,299 - $40,392	225 Added 13.24%	1,924 $315,000
Q2 2022 Aug 02, 2022	BUY	$168.19 - $186.01 $12,614 - $13,950	75 Added 4.62%	1,699 $302,000
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $632 - $718	4 Added 0.25%	1,624 $288,000
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $14,969 - $16,608	96 Added 6.3%	1,620 $277,000
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $9,044 - $10,050	56 Added 3.81%	1,524 $246,000
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $478 - $513	3 Added 0.2%	1,468 $242,000
Q1 2021 May 19, 2021	BUY	$153.07 - $170.48 $30,614 - $34,096	200 Added 15.81%	1,465 $241,000
Q4 2020 Mar 09, 2021	BUY	$137.11 - $157.38 $173,444 - $199,085	1,265 New	1,265 $199,000

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.